West-Ward Pharmaceuticals InternationalLimited – Trademark Portfolio
Entity Type: 99
West-Ward Pharmaceuticals InternationalLimited holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. The portfolio also extends into Class 40 (Treatment & Processing) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include WEST-WARD. The owner is based in London.
13 Hanover Square
London W1S1HW , GB
Showing of trademarks Trademarks
Trademark Classifications
West-Ward Pharmaceuticals InternationalLimited's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does West-Ward Pharmaceuticals InternationalLimited have?
West-Ward Pharmaceuticals InternationalLimited has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does West-Ward Pharmaceuticals InternationalLimited file in?
West-Ward Pharmaceuticals InternationalLimited files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are West-Ward Pharmaceuticals InternationalLimited's most well-known trademarks?
West-Ward Pharmaceuticals InternationalLimited's registered trademark portfolio includes well-known marks such as WEST-WARD. These are among 1 currently registered trademark in the portfolio.
What is West-Ward Pharmaceuticals InternationalLimited's trademark registration success rate?
West-Ward Pharmaceuticals InternationalLimited has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.